IFX-HU3.0

N/A

Report date: 2026/05/13 09:11:30

Base Information

Drug NameIFX-HU3.0

Drug Alias NamescFv-LNP-mRNA (Morphogenesis )Emm55 Streptococcal antigen mRNA (Morphogenesis )IFX-HU3.0IFX-HU-3.0

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMorphogenesis Inc

China Registration ClassN/A

Develop Information

Active CompaniesMorphogenesis Inc

Inactive CompaniesN/A

Active IndicationsLymphoma, Large B-Cell, Diffuse

Inactive IndicationsN/A

Other Information

ATC CodeN/A